Biopharm Company News - BioPharm International


Biopharm Company News
News from biopharmaceutical companies, including mergers, acquisitions, drug approvals, drug recalls.

Zymeworks, ImClone Systems to Develop Bi-specific Antibodies

January 9, 2014

Zymeworks has entered into a licensing and collaboration agreement with ImClone Systems to develop novel bi-specific antibody oncology therapeutics.

Genzyme Receives Complete Response Letter from FDA on Lemtrada Application

December 31, 2013

Genzyme plans to appeal FDA?s decision that the multiple-sclerosis treatment is not ready for approval.

Baxter Initiates Worldwide Voluntary Recall

December 30, 2013

Baxter International recalls dextrose injection and four sodium chloride injections.

Pfenex Awarded Anthrax Vaccine Contract

December 19, 2013

Leidos Holdings awards Pfenex a subcontract in support of the development of an anthrax vaccine.

Nearly 400 Drugs in Development for Infectious Diseases

December 16, 2013

Almost 400 new medicines for infectious diseases, including viral infections, bacterial infections, fungal infections and parasitic infections.

FDA Approves Extended-Release, Single-Entity Hydrocodone Product

October 28, 2013

Zhoydro ER is the first drug to have updated labeling now required for all ER/LA opioid analgesics.

Amarin Cuts Staff Following FDA Vote

October 23, 2013

Amarin cuts staff in half after an FDA committee rejects its product label expansion.

FDA Awards 15 Grants to Stimulate Drug, Device Development for Rare Diseases

October 22, 2013

FDA has awarded 15 grants totaling more than $14 million to boost the development of products for patients with rare diseases.

Merck Cuts 8,500 Positions, Moves Headquarters

October 1, 2013

Merck announced plans to reduce its workforce by 8,500 and move its headquarters in order to sharpen its commercial and R&D focus.



Click here